| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/24/2002 | WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005832A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 01/24/2002 | WO2002005822A2 Compositions containing therapeutically active components having enhanced solubility |
| 01/24/2002 | WO2002005820A1 Sildenafil citrate solid dispersions having high water solubility |
| 01/24/2002 | WO2002005817A1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence |
| 01/24/2002 | WO2002005816A1 A bioavailable dosage form of loratadine |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2002005809A1 Dermal for amino laevulinic acid |
| 01/24/2002 | WO2002005806A1 Pharmaceutical compositions comprising capsaicin for the treatment of pruritus ani |
| 01/24/2002 | WO2002005802A1 Method of fundamentally treating common cold |
| 01/24/2002 | WO2002005800A2 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 01/24/2002 | WO2002005799A2 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
| 01/24/2002 | WO2002005796A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | WO2002005790A1 Adhesive preparation |
| 01/24/2002 | WO2002005789A2 Solution-, dispersion- or emulsion-producing film dermatics |
| 01/24/2002 | WO2002005788A1 Composite solid shaped articles for the controlled delivery of biologically active ingredients |
| 01/24/2002 | WO2002005787A1 Production method for freeze-dried products |
| 01/24/2002 | WO2002005785A1 Modulated release therapeutic aerosols |
| 01/24/2002 | WO2002005784A1 A medicinal aerosol formulation |
| 01/24/2002 | WO2002005783A1 Water soluble microflake through air-gap and process therefore |
| 01/24/2002 | WO2002005782A2 Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/24/2002 | WO2002005763A1 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides |
| 01/24/2002 | WO2002005744A1 Method of moulding a pharmaceutical composition in a packaging material |
| 01/24/2002 | WO2001082872A3 A medicinal aerosol formulation |
| 01/24/2002 | WO2001078761A3 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
| 01/24/2002 | WO2001076553A3 Method and device for enhanced transdermal drug delivery |
| 01/24/2002 | WO2001066104A3 Retinoid formulations for aerosolization and inhalation |
| 01/24/2002 | WO2001051071A3 Transepithelial delivery of glp-1 derivatives |
| 01/24/2002 | WO2001049822A3 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 01/24/2002 | WO2001045640A3 Barrier-forming composition |
| 01/24/2002 | WO2001041785A3 Enzyme treatment for infection |
| 01/24/2002 | WO2001039744A3 Radiation sensitive liposomes |
| 01/24/2002 | WO2001032157A3 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 01/24/2002 | WO2001030337A3 Ophthalmic formulation of dopamine antagonists |
| 01/24/2002 | WO2001030336B1 Pharmaceutical formulations comprising resveratrol and use thereof |
| 01/24/2002 | WO2001022936A8 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2001006987A3 Transnasal anticonvulsive compositions and modulated process |
| 01/24/2002 | US20020010693 Integrated hangtag production system |
| 01/24/2002 | US20020010462 Method of drug delivery to interstitial regions of the myocardium |
| 01/24/2002 | US20020010415 System and method for assessing the performance of a pharmaceutical agent delivery system |
| 01/24/2002 | US20020010357 Heat resistance dosage forms |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010201 Method for treating restless leg syndrome using pramipexole and clonidine |
| 01/24/2002 | US20020010198 Treatment of eating disorders, obesity, irritable bowel syndrome, obsessive-compulsive disorders, platelet adhesion, male and female sexual function disorders, restless leg syndrome, osteoarthritis |
| 01/24/2002 | US20020010194 Administering intranasally a local anesthetic selected from bupivacaine and ropivacaine |
| 01/24/2002 | US20020010193 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
| 01/24/2002 | US20020010187 5-((4-(3-methyl-4-oxo-3,4-dihydro-2 -quinazolinyl)methoxy)phenylmethyl)thiazolidine-2 ,4-dione or a pharmaceutically acceptable salt thereof |
| 01/24/2002 | US20020010166 Crystalline progestagens |
| 01/24/2002 | US20020010164 Low oxygen content compositions of 1alpha, 25-dihydroxycholecalciferol |
| 01/24/2002 | US20020010142 Parasiticidal formulation and a method of making this formulation |
| 01/24/2002 | US20020010131 Reductive alkylation process |
| 01/24/2002 | US20020010130 Adding purified fibronectin to basic water; wound healing gels |
| 01/24/2002 | US20020010128 Treating atopic dermatitis and/or skin photodamage, by administering a HMG-CoA reductase (3-hydroxy-3-methylglutaryl coenzyme A reductase) inhibitor |
| 01/24/2002 | US20020010127 Dosage form; antagonist to attenuate a side effect of said opioid agonist; analgesia for at least about eight hours when administered to human patients |
| 01/24/2002 | US20020009789 Powder containing physiologically active peptide |
| 01/24/2002 | US20020009783 Aqueous solutions comprising a polysaccharide oncotic agent, a physiologically compatible buffer, a simple hexose sugar, dissolved chloride salt of sodium, calcium and magnesium and an organic acid or salt or ester, substitute for blood |
| 01/24/2002 | US20020009706 Method for loading cells with an agent |
| 01/24/2002 | US20020009522 Coating material and coated powder |
| 01/24/2002 | US20020009507 Antiinflammatory agents; mimic or enhance tears |
| 01/24/2002 | US20020009502 Water, sodium chloride, potassium chloride, sodium citrate, potassium citrate, carbohydrates and structuring agents; masks unpleasant tastes |
| 01/24/2002 | US20020009497 Low dosage level of 5-fluorouracil; sustained release with a porous polymeric bead; side effect reduction |
| 01/24/2002 | US20020009496 Spraying a suspension of microionized fenofibrate and polyvinylpyrrolidone onto an inert hydrosoluble carrier; immediate-release; improved dissolution |
| 01/24/2002 | US20020009494 Spray drying |
| 01/24/2002 | US20020009493 Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
| 01/24/2002 | US20020009492 Crosslinked polymer |
| 01/24/2002 | US20020009489 Atopic dermatitis treatment method |
| 01/24/2002 | US20020009488 Tissue entrapment |
| 01/24/2002 | US20020009486 Therapeutic agent delivery incorporating reflective optical film |
| 01/24/2002 | US20020009485 Drug delivery via therapeutic hydrogels |
| 01/24/2002 | US20020009483 Topical administration of oxazolidinones for transdermal delivery |
| 01/24/2002 | US20020009478 Aqueous liquid containing colloidal particles |
| 01/24/2002 | US20020009474 Calcium supplements entainment in hydrophilic polymer; bioavailability |
| 01/24/2002 | US20020009466 Encapsulating antigen in biopolymer |
| 01/24/2002 | US20020009464 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/24/2002 | US20020009463 Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/24/2002 | US20020009457 Water in oil emulsion |
| 01/24/2002 | US20020009456 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 01/24/2002 | US20020009431 Method for transplanting cells into the brain and therapeutic uses therefor |
| 01/24/2002 | US20020009418 Dry powder formulations of antihistamine for nasal administration |
| 01/24/2002 | US20020009415 Microspheres for use in the treatment of cancer |
| 01/24/2002 | DE10053375C1 Transdermal therapeutic system with light-sensitive agent in polymer matrix and backing, useful for therapy with e.g. nicotine, nifedipine, lacidipine, gestagen, vitamin B 12 or antibiotic, contains colorless ultraviolet absorber |
| 01/24/2002 | DE10045374A1 Sustained release microparticles and their preparation using a multi-emulsion process, for delivery of drugs for up to 6 months or longer |
| 01/24/2002 | DE10034663A1 Device for facilitating oral administration of medicaments to animals, e.g. cats, comprises treatment formed in two parts and including cavity for insertion of medicament |
| 01/24/2002 | DE10034491A1 Folien-Dermatika Foil dermatics |
| 01/24/2002 | DE10033283A1 Verwendung eines flüssigen Medikamentes zur Behandlung von Dissektionsebenen Resektionsflächen an einer biologischen Struktur und zur gleichzeitigen Trennung der biologischen Struktur und Hochdruckflüssigkeitsstrahleinrichtung zur Durchführung des Verfahrens Use of a liquid medicament for the treatment of Dissektionsebenen resection surfaces on a biological structure, and for the simultaneous separation of the biological structure and high pressure liquid jet means for performing the method |
| 01/24/2002 | DE10032434A1 Verwendung von Dicalciumphosphatanhydrid-Pulver Use of dicalcium phosphate anhydride powder |
| 01/24/2002 | CA2417736A1 Sildenafil citrate solid dispersions having high water solubility |
| 01/24/2002 | CA2416698A1 Hydrogel films and methods of making and using therefor |
| 01/24/2002 | CA2416004A1 Method for encapsulating fine solid particles in the form of microcapsules |
| 01/24/2002 | CA2415922A1 Pharmaceutical compositions containing dds compound |
| 01/24/2002 | CA2415697A1 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
| 01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2415128A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |